6-K 1 dp86825_6k.htm FORM 6-K

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE 

 SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2018

 

Commission File Number: 001-13742

 

ISRAEL CHEMICALS LTD. 

(Exact name of registrant as specified in its charter)

 

Israel Chemicals Ltd. 

Millennium Tower 

23 Aranha Street 

P.O. Box 20245 

Tel Aviv, 61202 Israel 

(972-3) 684-4400 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F   Form 40-F  

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes     No

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes     No X

 

 

 

ISRAEL CHEMICALS LTD.

 

 INCORPORATION BY REFERENCE

 

This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

 

 

ISRAEL CHEMICALS LTD.

 

  1.

End of Tenure of Director – Mr. Geoffery Merszei

 

 

 

 

Item 1

 

End of Tenure of Director – Mr. Geoffery Merszei

 

The Company hereby reports that Mr. Geoffery Merszei, a member of the Company's Board of Directors, informed the Chairman of the Board that after three years of service he decided to step down, for personal reasons, with immediate effect.

 

The Board of Directors thanks Mr. Merszei for his great contribution to the Company.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Israel Chemicals Ltd.
   
  By: /s/ Kobi Altman
    Name: Kobi Altman
    Title: Chief Financial Officer
       
  Israel Chemicals Ltd.
   
  By: /s/ Lisa Haimovitz
    Name: Lisa Haimovitz
    Title: Senior Vice President, Global General Counsel and Corporate Secretary

Date: February 14, 2018